A glimpse into a Penta Youth Trial Boards Meeting
15 Nov, 2022
The Penta Youth Trials Board (YTB) is made up of young people aged between 15 – 19 from South Africa, Uganda, Zimbabwe and the UK. The YTBs ensure that children and young people…
Read More
EPIICAL General Assembly meeting to reaffirm mission to achieve HIV remission in children
14 Nov, 2022
The EPIICAL General Assembly was held online and in person in Venice on 2-4 November 2022. It brought together 80 participants from 29 organisations from the EPIICAL consortium. Attendees came…
Read More
Join our next Penta Aperitivo on 10 November 2022!
04 Nov, 2022
The Penta Aperitivo webinars are here to keep you up to date with the latest Penta activities and on the new developments on the prevention, diagnosis, and treatment of infectious diseases in children. The…
Read More
Science4Pandemics presents two Citizen Science projects
04 Nov, 2022
The digital platform Science4Pandemics, in which we are a partner, has launched two new citizen science projects for adolescents between the ages of 12 and 17, as well as their parents, to collaborate with…
Read More
PentaTr@ining: HIV & other Congenital Infections draws to a close
31 Oct, 2022
This year’s edition of our innovative training course “PentaTr@ining: HIV & other Congenital Infections” finally drew to a close at the end of September, and we are delighted to report…
Read More
Integrating Social Sciences into clinical research: an opportunity for achieving greater impact
28 Sep, 2022
Quantitative and qualitative data have a mutually beneficial relationship. Quantitative data need the depth of qualitative evidence to be adequately interpreted, and qualitative evidence benefits from being based on robust…
Read More
Penta endorses the People First Charter
27 Sep, 2022
The People First Charter was launched on 20th July 2021 to promote person-first language in the field of HIV. We are proud to endorse this much-needed charter which will ensure…
Read More
PentaTr@ining: Fungal Infections in Paediatrics – Online course kicks off
19 Sep, 2022
On September 19, 2022, we kicked off our exciting new online course, “Fungal Infections in Paediatrics” on our PentaTr@ining platform, with over 100 delegates logging in from across the world.…
Read More
Join one of the UK’s leading Clinical Trials Units
15 Sep, 2022
The position of Senior Clinical Research Fellow is now available at the MRC CTU. The position is open to clinicians with experience in the management of infectious diseases, in particular…
Read More
Dolutegravir-based HIV treatment is better for babies and young children
31 Aug, 2022
Babies and young children treated with the anti-HIV drug dolutegravir, in combination with other anti-HIV drugs, are more likely to keep the virus under control, compared to those treated with…
Read More
Registrations are open for the PentaTr@ining course: ‘Fungal Infections in Paediatrics’
18 Aug, 2022
We are happy to announce that registrations are now open for our new interactive training course ‘Fungal Infections in Paediatrics‘! Building on the combined expertise within the European Paediatric Mycology…
Read More
CARMA Global sites prepared and ready to enrol
11 Aug, 2022
CARMA Global is an EPIICAL cross-sectional, multi-country, multi-site, low interventional study on children, adolescents and youth who started ART at three months or younger at least seven years ago and…
Read More
Penta endorses the International workshop on HIV and adolescence
26 Jul, 2022
We are proud to endorse the International Workshop on HIV and adolescents taking place from 5-6 October 2022, in Cape Town, South Africa. The workshop brings together experts from across…
Read More
PentaTr@ining holds first-ever jointly hosted course in Africa
26 Jul, 2022
The PentaTr@ining Zambia-Tanzania 2022 course was held on 18-20 July. It was Penta’s first-ever jointly hosted training course in Africa and it counted more than 200 participants with nearly 150…
Read More
Double dose of dolutegravir to treat HIV in children also being treated for tuberculosis
20 Jul, 2022
Results from a substudy of the ODYSSEY trial show that children being treated for tuberculosis (TB) and HIV at the same time can safely have the anti-HIV medicine dolutegravir twice…
Read More
2nd VERDI General Assembly highlights importance of synergies across cohorts and consortia
15 Jul, 2022
The second VERDI General Assembly took place from 28-30 June 2022, bringing together more than 70 people both online and in Padua, Italy. This hybrid meeting spotlighted the important work…
Read More
Combining Factorial and MAMS designs
06 Jul, 2022
The methodology team at the MRC Clinical Trials Unit at UCL is a key partner of Penta and has made a huge contribution to our studies on HIV. The team…
Read More
Study reveals moderate effectiveness of Pfizer-BioNTech’s Covid-19 vaccine against Omicron in children aged 5-11
30 Jun, 2022
A large study on the effectiveness of the Pfizer-BioNTech’s Covid-19 vaccine in children aged 5-11 was published in The New England Journal of Medicine. The study was conducted at Israel’s…
Read More